Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...
More investors want their money to reflect their values. It feels righteous — but the reality is a lot messier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results